Skip to main content
SpringerLink
Log in

Alemtuzumab

Hypertension and erythematous and pruritic skin rashes: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Krishnan P, et al. Alemtuzumab in highly active multiple sclerosis (HAMS): Experience with unlikely patients and unusual challenges. Multiple Sclerosis Journal 26: NP61, No. 9, Aug 2020. Available from: URL: http://doi.org/10.1177/1352458520925277 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1836, 36 (2021). https://doi.org/10.1007/s40278-021-87855-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-87855-0

Search

Navigation